Document Classification

Section Type: RESULTS

Text: In subjects administered Xalatan, intraocular pressure (IOP) showed a greater decrease (P < 0. 001) from 23. 64 + / - 3. 13 mmHg at baseline to 14. 29 + / - 1. 61 mmHg at week 12 (fall of 9. 35 + / - 3. 55 mmHg, 38. 66 % + / - 10. 29) than that seen in the Latoprost group (22. 74 + / - 2. 47 mmHg to 16. 98 + / - 2. 49 mmHg, fall of 5. 76 + / - 1. 41 mmHg ; 25. 42 % + / - 5. 98).